Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status María I. NunezJohn Ludes-MeyersC. Marcelo Aldaz Report Pages: 99 - 105
A comparison of record linkage yield for health research using different variable sets Michael S. SimonBeth A. MuellerGlenn Copeland Report Pages: 107 - 110
Breast cancer screening barriers and mammography completion in older minority women Rosalie F. YoungRichard K. Severson Report Pages: 111 - 118
Usefulness of three-dimensional multidetector-row CT images for preoperative evaluation of tumor extension in primary breast cancer patients Tomoo InoueYasuhiro TamakiShinzaburo Noguchi Report Pages: 119 - 125
Ultrasound criteria for ductal invasive breast cancer are modified by age, tumor size, and axillary lymph node status Dirk O. WatermannClemens B. TempferElmar Stickeler Report Pages: 127 - 133
Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response Lisa RydénMaria StendahlGöran Landberg Report Pages: 135 - 143
Breast hamartoma: a case report Giovanna GattiGiovanni MazzarolGiuseppe Viale Report Pages: 145 - 147
Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry Timothy M. PawlikHerbert FritscheHenry M. Kuerer Report Pages: 149 - 157
The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology Alberto LuiniViviana GalimbertiGiovanni Paganelli Report Pages: 159 - 163
A multicentre phase II study on gefitinib in taxane- and anthracycline-pretreated metastatic breast cancer Gunter von MinckwitzWalter JonatAndreas Schneeweiss Report Pages: 165 - 172
Hazard rates of recurrence following diagnosis of primary breast cancer Ismail JatoiAnna TsimelzonSusan G. Hilsenbeck Report Pages: 173 - 178
Automatic ultrasound segmentation and morphology based diagnosis of solid breast tumors Ruey-Feng ChangWen-Jie WuDar-Ren Chen Report Pages: 179 - 185
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory Kathy D. MillerSharon E. SouleGeorge W. Sledge Jr Report Pages: 187 - 197
cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: implications for breast tumor invasion Yan-gao ManYi ZhangBrian L Strauss Report Pages: 199 - 208
Inhibition of metastasis by inhibition of tumor-derived CCL5 Kerry A. StormesCharles A. LemkenRobert A. Kurt Brief communication Pages: 209 - 212
Endogenous estrogen levels, bone mineral density and estrogen receptor status in breast cancer Kadri AltundagOzden AltundagMehmet Gunduz Letter to the editor Pages: 213 - 213